Page last updated: 2024-10-28

fasudil and Retinal Neovascularization

fasudil has been researched along with Retinal Neovascularization in 1 studies

fasudil: intracellular calcium antagonist; structure in first source
fasudil : An isoquinoline substituted by a (1,4-diazepan-1-yl)sulfonyl group at position 5. It is a Rho-kinase inhibitor and its hydrochloride hydrate form is approved for the treatment of cerebral vasospasm and cerebral ischemia.

Retinal Neovascularization: Formation of new blood vessels originating from the retinal veins and extending along the inner (vitreal) surface of the retina.

Research Excerpts

ExcerptRelevanceReference
"The aim of the study was to evaluate the effect of the RhoA/ROCK inhibitor Fasudil on retinal neovascularization (NV) in vivo and angiogenesis in vitro."4.31RhoA/ROCK Signaling Is Involved in Pathological Retinal Neovascularization. ( Deng, W; Huang, K; Peng, B; Su, N; Tang, F; Xu, F; Zhang, M; Zhong, H, 2023)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Tang, F1
Huang, K1
Peng, B1
Deng, W1
Su, N1
Xu, F1
Zhang, M1
Zhong, H1

Other Studies

1 other study available for fasudil and Retinal Neovascularization

ArticleYear
RhoA/ROCK Signaling Is Involved in Pathological Retinal Neovascularization.
    Journal of vascular research, 2023, Volume: 60, Issue:4

    Topics: Animals; Disease Models, Animal; Human Umbilical Vein Endothelial Cells; Humans; Mice; Mice, Inbred

2023